Progress toward an elusive goal: current status of cytomegalovirus vaccines.

@article{Schleiss2005ProgressTA,
  title={Progress toward an elusive goal: current status of cytomegalovirus vaccines.},
  author={Mark R. Schleiss and Thomas C. Heineman},
  journal={Expert review of vaccines},
  year={2005},
  volume={4 3},
  pages={381-406}
}
Although infection with human cytomegalovirus (CMV) is ubiquitous and generally asymptomatic in most individuals, certain patient populations are at high risk for CMV-associated disease. These include HIV-infected individuals with AIDS, transplant patients, and newborn infants with congenital CMV infection. Immunity to CMV infection, both in the transplant… CONTINUE READING